| [1] |
Li SS, Tseng HM, Yang TP, et al. Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan [J]. Hum Genet,1999,104(3):201-204.
|
| [2] |
Tang NL, Pang CP, Yeo W, et al. Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer[J]. J Natl Cancer Inst,1999, 91(10):882-885.
|
| [3] |
Li WF, Hu Z, Rao NY, et al. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified [J]. Breast Cancer Res Treat,2008,110 (1): 99-109.
|
| [4] |
National Human Genome Research Institute. Breast Cancer Information Core. [2009-05-10] http:/ / research. nhgri. nih.gov/bic/ .
|
| [5] |
De Benedetti VM, Radice P, Pasini B, et al. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online[J]. Hum Mutat,1998,12 (3):215.
|
| [6] |
Gal I, Gershoni Baruch R, Haber D,et al. The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non- Ashkenazi Jews and haplotype comparison of Jewish and non- Jewish carriers [J]. Fam Cancer,2004, 3 (1):11-14.
|
| [7] |
Thirthagiri E, Lee SY, Kang P, et al. Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer [J]. Breast Cancer Res,2008,10(4):R59.
|
| [8] |
Suter NM, Ray RM, Hu YW, et al. BRCA1 and BRCA2 mutations in women from Shanghai China [J]. Cancer Epidemiol Biomarkers Prev,2004,13(2):181-189.
|
| [9] |
Choi DH, Lee MH, Bale AE, et al. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients [J].J Clin Oncol,2004,22(9):1638-1645.
|
| [10] |
Li N, Zhang X, Cai Y, et al. BRCA1 germline mutations in Chinese patients with hereditary breast and ovarian cancer [J].Int J Gynecol Cancer,2006,16(Suppl 1):172-178.
|
| [11] |
胡震,李文凤,柳晓义,等.115 例家族性乳腺癌患者中的BRCA1 和BRCA2 基因突变[J]. 中华医学杂志,2008,88(34):1-4.
|
| [12] |
Armes JE, Egan AJ, Southey MC, et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations[J]. Cancer,1998,83: 2335-2345
|
| [13] |
胡震,李文凤,柳晓义,等.中国BRCA1 基因突变相关性乳腺癌和散发性乳腺癌的比较研究[J].中华外科杂志,2007,45(7):489-490.
|
| [14] |
Lidereau R, Eisinger F, Champeme MH, et al. Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer [J]. Cancer Res,2000,60(5): 1206-1210.
|
| [15] |
Berry DA, Iversen ES Jr, Gudbjartsson DF, et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2,and prevalence of other breast cancer susceptibility genes [J]. J Clin Oncol, 2002, 20 (11): 2701-2712.
|
| [16] |
Rao NY, Hu Z, Yu JM, et al. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients [J]. Breast Cancer Res Treat,2009, 116(3):563-570.
|
| [17] |
Rao NY, Hu Z, Li WF, et al. Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients [J]. Breast Cancer Res Treat,2009, 113 (3): 467-477.
|
| [18] |
宋传贵,胡震,袁文涛,等. CHEK2 基因c.1100delC 与中国人遗传性乳腺癌易感性的关联研究[J].中华医学遗传学杂志,2006,23(4):443-445.
|
| [19] |
Hu Z, Song CG, Lu JS, et al. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER alpha,COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives [J].J Cancer Res Clin Oncol,2007,133 (12): 969-978.
|